头颈部HPV相关神经内分泌癌的细针穿刺活检:罕见实体的临床病理特征
该研究在2个机构3年内识别5例头颈部HPV相关神经内分泌癌(HPV-NEC)的细针穿刺(FNA)病例,均来自4例颈部淋巴结转移患者。肿瘤表达突触素和p16,p63/p40阴性,HPV检测证实4例原位杂交阳性、1例PCR检出HPV-18。结论认为HPV-NEC罕见且侵袭性强,p16阳性非特异,需确认性HPV检测,且预后较HPV相关鳞癌差。
要点
- 头颈部HPV-NEC罕见,FNA可表现为小细胞、大细胞或混合性神经内分泌形态。
- 肿瘤强表达突触素和p16,p63/p40阴性,但p16阳性非特异,需HPV检测确认。
- Rb染色中至弱、p53弱阳性,诊断价值有限;HPV-NEC预后较HPV相关鳞癌差。
核心结论
- 头颈部HPV-NEC是罕见、侵袭性实体,可呈混合小细胞和大细胞特征及p16上调。
- p53和Rb表达可变,诊断价值有限;p16阳性可非特异,需确认性HPV检测。
研究设计与样本
- 回顾性研究,2个机构3年期内识别5例HPV-NEC的FNA病例,来自4例患者。
- 评估临床、细胞形态学及辅助检测结果。
主要发现
- 5例FNA均来自颈部淋巴结转移,原发部位为口咽(n=2)、鼻咽(n=1)和喉(n=1)。
- 3例呈混合小细胞和大细胞神经内分泌形态,1例为小细胞癌,1例为大细胞神经内分泌癌。
- 所有肿瘤突触素和p16强阳性,p63/p40阴性;2例INSM1显示弥漫核染色。
- 4例原位杂交证实HPV,第5例PCR检出HPV-18。
- Rb染色中至弱(5/5),p53弱阳性(5/5)。
关键数值与推荐
- 所有肿瘤突触素和p16强阳性,p63/p40阴性。
- 2例INSM1弥漫核染色;4例HPV原位杂交阳性,1例PCR检出HPV-18。
- Rb染色中至弱(5/5),p53弱阳性(5/5)。
临床怎么用
- FNA诊断头颈部神经内分泌癌时,应加做p16和HPV检测以确认HPV关联。
- p16阳性非特异,需HPV确认性检测,可能有助于 unknown primary 神经内分泌癌的原发部位判断。
- 准确诊断HPV-NEC重要,因其预后较HPV相关鳞状细胞癌差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The majority of human papillomavirus (HPV)-associated oropharyngeal carcinomas are squamous cell carcinomas; however, there are rare reports of HPV-associated neuroendocrine carcinomas (HPV-NECs) in the upper aerodigestive tract. The aim of this study was to characterize the diagnostic features of fine-needle aspiration (FNA) cases of head and neck HPV-NEC. METHODS: Cytology cases of HPV-NEC were identified over a 3-year period from 2 institutions. Clinical, cytomorphologic, and ancillary test results were evaluated. RESULTS: Five FNA cases of HPV-NEC were identified from 4 patients with cervical lymph node metastases with primaries in the oropharynx (n = 2), nasopharynx (n = 1), and larynx (n = 1). Three cases showed mixed small cell and large cell neuroendocrine morphologies; 1 case was a small cell carcinoma, and the last case appeared as a large cell neuroendocrine carcinoma. All tumors were strongly positive for synaptophysin and p16 and negative for p63/p40. Two cases tested for INSM1 showed diffuse nuclear staining. HPV was confirmed by in situ hybridization in 4 cases, and HPV-18 was detected by polymerase chain reaction in the fifth case. Retinoblastoma (Rb) staining was moderate to weak (5/5), and p53 was weakly positive (5/5). CONCLUSIONS: Head and neck HPV-NEC is a rare, aggressive entity that can show mixed small and large cell features and p16 upregulation; p53 and Rb are variable with limited diagnostic utility. Because p16 positivity can be nonspecific, confirmatory HPV testing is required and may be helpful in determining the primary site for neuroendocrine carcinoma of an unknown primary. The accurate diagnosis of HPV-NEC is also important because of its worse prognosis in comparison with HPV-associated squamous cell carcinoma.
引用
- Jo VY, Krane JF, Pantanowitz L, et al. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity. Cancer Cytopathol. 2018. PMID: 30475447. doi:10.1002/cncy.22075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。